Related Experiment Video
Updated: Jul 6, 2026

The Measurement and Treatment of Suppression in Amblyopia
Published on: December 14, 2012
[Experience with complex treatment for childhood amblyopia]
Insights
Mexidole significantly improved vision treatment in children with amblyopia (lazy eye). This drug enhanced pleoptic treatment effectiveness and maintained visual function, showing positive effects on visually evoked potentials.
Area of Science:
- Ophthalmology
- Pediatric Neurology
- Pharmacology
Background:
- Amblyopia, or lazy eye, affects visual development in children.
- Effective treatment strategies are crucial for achieving stable visual function.
- Pleoptic treatment is a common approach for managing amblyopia.
Purpose of the Study:
- To evaluate the efficacy of mexidole as an adjunct therapy for amblyopia in children.
- To assess the impact of mexidole on the efficiency and stability of visual function.
- To investigate the effect of mexidole on visually evoked potentials (VEPs).
Main Methods:
- A study group of 36 children with amblyopia received standard pleoptic treatment plus mexidole.
- A control group of 30 children with amblyopia received only pleoptic treatment.
- Visually evoked potentials were measured to assess visual pathway function.
Main Results:
- Mexidole enhanced the effectiveness of complex pleoptic treatment in 83% of cases.
- The addition of mexidole led to sustained visual function improvements.
- Mexidole demonstrated a positive influence on visually evoked potential values.
Conclusions:
- Mexidole is an effective therapeutic agent for improving amblyopia treatment outcomes in children.
- Adjunctive mexidole therapy promotes long-term visual function stability.
- Mexidole positively modulates neurophysiological responses in the visual system.
Abstract:
The effects of mexidole on the higher efficiency of treatment for diseases involving the visual nerve apparatus and on the achievement of stable visual function were studied in children. The study covered a study group of 36 children aged 5 to 12 years (mean 8.50 +/- 0.56 years) who had amblyopla of various genesis. A control group comprised 30 patients (mean age was 8.20 +/- 0.56 years) who had also amblyopia of various genesis and 25 healthy children (mean age was 8.20 +/- 0.63 years). The patients of the first two groups received the similar course pleoptic treatment. Those of the study group were additionally given mexidole by the conventional regimen. Mexidole used in children with amblyopia enhanced the efficiency of complex pleoptic treatment in 83% of cases and long maintained the visual functions achieved during stimulation. The agent has a positive effect on the values of visually evoked potentials.
Related Concept Videos
Angle Closure Glaucoma: Treatment
Open Angle Glaucoma: Treatment
Drugs such as carbonic anhydrase inhibitors, α2- and...